Otsuka Pharmaceutical Factory has signed an agreement to acquire 20% of outstanding shares in Otsuka Pharmaceutical India Private (OPI).

The shares are currently held by Claris Lifesciences, a pharmaceutical company based in India.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

"German biopharmaceutical company Sygnis has agreed to acquire UK-based Innova Biosciences."

Based in Japan, the acquirer company manufactures and distributes industrial and pharmaceutical chemicals.

The purchase consideration for the acquisition is $20m.

German biopharmaceutical company Sygnis has agreed to acquire UK-based Innova Biosciences.

The purchase consideration for the acquisition will include €8m ($8.79m) in cash and up to 3.5 million in shares.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Pharmaceutical Technology Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Pharmaceutical Technology Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now